Adalimumab Prefilled Syringe for Psoriasis Treatment from Japan
Humira-brand adalimumab, a TNF inhibitor monoclonal antibody in 40mg prefilled syringes for retail sale, used prophylactically against autoimmune psoriasis flares. Classified in HTS 3002.15.00.91 as a biotechnological immunological product in measured retail doses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit FDA Import Alert 66-42 screening docs to avoid detention for unapproved biologics
• Verify serial numbers for anti-counterfeiting; common pitfall is incomplete pedigree records
• Confirm 'retail sale' packing with consumer instructions to differentiate from institutional bulk